US 10086041
Syndecan-4 proteoliposomes for enhanced cutaneous wound healing and minimized inflammatory immune response
granted A61KA61K38/177A61K38/179
Quick answer
US patent 10086041 (Syndecan-4 proteoliposomes for enhanced cutaneous wound healing and minimized inflammatory immune response) held by The Board of Regents of the University of Texas System expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/177, A61K38/179, A61K38/1858, A61K9/0014